Gendux Announces Acceptance of Its ADVEXIN Marketing Authorization Application for Review by the European Medicines Evaluation Agency
11/27/2007 12:11:41 PM
More...
|
Introgen Therapeutics, Inc. (INGN) and Gendux Submit First Marketing Authorization Application for ADVEXIN
11/13/2007 10:31:19 AM
More...
|
Introgen Therapeutics, Inc. (INGN) And Gendux Announce Agreement With European Medicines Agency To File For ADVEXIN Approval Under Exceptional Circumstance Rules
10/31/2006 11:31:56 AM
More...
|
Introgen Therapeutics, Inc. (INGN) And Gendux Announce Orphan Designation For ADVEXIN Therapy In European Union
9/7/2006 1:49:04 PM
More...
|